|
|
 |
|
Viewing report
|
|
|
|
Vital Signs: Market Movements within Healthcare
Frost & Sullivan, June 2012
Vital Signs is a frequent advisory from Frost & Sullivan that provides strategic viewpoints and timely updates on the most significant market movements within Healthcare. Developed by Frost & Sullivan’s team of industry experts and delivered twice monthly, each Vital Signs issue offers concise, real-time information and strategies for market participants.
The Vital Signs subscription is delivered in two issue formats every month, Vital Signs and Vital Signs: The Analyst’s Perspective.
Vital Signs contain the following elements:
Strategic Insight Article
The Strategic Insight Article provides healthcare executives with strategic insights and opinions on the most notable issues impacting healthcare markets today and in the future. This thought-provoking analysis focuses on:
- News, strategies, and innovations that are occurring in that sector
- Near and Long-term impact assessments on companies directly involved in the market sector, as well as the ripple effects on other industry participants and players
- Revealing unidentified activities in the immediate product or technology market, and also in related or complementary industry segments
Access to information from various sectors helps organizations identify market expansion opportunities and pinpoint possible areas of technology convergence, leading to expansive growth possibilities.
Company Spotlight
The Company Spotlight highlights emerging companies in the market, companies at the forefront of innovation, and companies that excel at providing unique and groundbreaking industry products and solutions. This information allows industry leaders and financial services firms to identify and monitor companies that may prove to be ideal technology partners or acquisition targets. In addition, this information keeps market participants in tune with emerging industry competitors and their potentially disruptive technologies.
Reimbursement & Regulatory News
Clients receive details of the latest regulatory news, including FDA approvals for pharmaceuticals, medical devices, and other medical technologies. Clients also may receive information regarding procedures, indications, and devices that have recently qualified for payment by Medicare or other payers, thereby keeping them up-to-date on the novel treatments that may enter the market in the near future.
Vital Signs: The Analyst’s Perspective contains the following elements:
Vital Signs: The Analyst’s Perspective provides short, direct analyst insight and commentary on the hottest developments and news announcements in healthcare. Each issue contains analyst contributions across multiple areas, exposing clients to news, strategy and innovation occurring in different parts of the healthcare market, allowing them to think about market expansion opportunities and possible areas of technology convergence.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
